Ipsen is a global biopharmaceutical group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
Our long‐term commitment to advancing neuroscience and toxins research is evidenced by over 25 years of clinical experience. We are fully committed to improving people’s lives through safe and effective treatments, support and services in spasticity, movement disorders and specific indications in aesthetic medicine.
At our R&D centers around the world & through numerous collaborative projects & partnerships with top academic institutes and investigators, we are pioneering research into neurotoxins. We have a leading-edge protein engineering expertise in toxins and we're pushing the boundaries of neurotoxin research to provide innovation.